[ARAY] Accuray Incorporated


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 432.92 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 4.6 Change: -0.15 (-3.16%)
Ext. hours: Change: 0 (0%)

chart ARAY

Refresh chart

Strongest Trends Summary For ARAY

ARAY is in the medium-term down -52% below S&P in 1 year. In the long-term down -62% in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilit

Fundamental Ratios
Shares Outstanding80.92 M EPS-0.38 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -4.4% Sales Growth - Q/Q-0.65% P/E-11.45
P/E To EPS Growth P/S1.14 P/BV5.66 Price/Cash Per Share2.84
Price/Free Cash Flow-37.37 ROA-9.58% ROE-58.08% ROI-15.43%
Current Ratio2.1 Quick Ratio1.44 Long Term Debt/Equity1.1 Debt Ratio2.17
Gross Margin37.73% Operating Margin-5.88% Net Profit Margin-11.69% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.71 M Cash From Investing Activities18.63 M Cash From Operating Activities-12.6 M Gross Profit38.66 M
Net Profit-2.97 M Operating Profit1.17 M Total Assets463.66 M Total Current Assets347.97 M
Total Current Liabilities165.79 M Total Debt200.99 M Total Liabilities387.18 M Total Revenue97.52 M
Technical Data
High 52 week5.28 Low 52 week3.31 Last close3.56 Last change-4.04%
RSI35.48 Average true range0.17 Beta1.14 Volume646.59 K
Simple moving average 20 days-7.48% Simple moving average 50 days-5.85% Simple moving average 200 days-14.65%
Performance Data
Performance Week-8.25% Performance Month-2.47% Performance Quart-14.01% Performance Half-30.47%
Performance Year-6.32% Performance Year-to-date4.4% Volatility daily2.83% Volatility weekly6.32%
Volatility monthly12.95% Volatility yearly44.86% Relative Volume806.1% Average Volume579.13 K
New High New Low-1.08%


2020-06-01 09:56:01 | Here's Why You Should Add Accuray to Your Portfolio Now

2020-05-28 11:30:03 | Why Is Accuray ARAY Down 9.2% Since Last Earnings Report?

2020-05-19 08:00:00 | Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System Wins 2020 MedTech Breakthrough Award

2020-05-14 08:48:12 | Delivery Robots Making an Impression Amid Coronavirus Pandemic

2020-05-08 00:26:28 | Edited Transcript of ARAY earnings conference call or presentation 28-Apr-20 8:30pm GMT

2020-05-07 10:23:02 | How Accuray ARAY Stock Stands Out in a Strong Industry

2020-05-03 09:01:24 | Does Accuray Incorporated's NASDAQ:ARAY CEO Pay Compare Well With Peers?

2020-05-03 08:26:23 | Accuray Incorporated Just Reported A Surprise Profit And Analysts Updated Their Estimates

2020-05-01 12:20:04 | Will Accuray ARAY Gain on Rising Earnings Estimates?

2020-05-01 12:00:04 | What Makes Accuray ARAY a New Strong Buy Stock

2020-04-29 10:39:02 | Accuray ARAY Earnings and Revenues Beat Estimates in Q3

2020-04-28 21:01:39 | Accuray Inc ARAY Q3 2020 Earnings Call Transcript

2020-04-28 19:05:11 | Accuray ARAY Beats Q3 Earnings and Revenue Estimates

2020-04-28 16:05:00 | Accuray Reports Fiscal 2020 Third Quarter Financial Results

2020-04-20 08:27:12 | Here's Why You Should Retain Accuray in Your Portfolio

2020-04-16 17:43:00 | Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020

2020-03-27 08:46:12 | Here's Why You Should Invest in DaVita DVA Stock Right Now

2020-03-26 10:25:02 | Here's Why You Should Hold On to PerkinElmer PKI Stock Now

2020-03-19 09:50:01 | Here's Why You Should Hold Onto Baxter BAX Stock for Now

2020-03-19 09:21:01 | Accuray Enters Oversold Territory

2020-03-18 10:26:02 | NextGen's New Platform Set to Improve Patient Engagement

2020-03-17 10:24:02 | HealthEquity HQY Q4 Earnings and Revenues Top Estimates

2020-03-17 09:53:01 | Baxter BAX Q4 Earnings Beat Estimates, Revenues In Line

2020-03-16 10:23:02 | Here's Why You Should Hold Onto Varian Medical Stock Now

2020-03-13 09:49:01 | Here's Why You Should Buy Cooper Companies COO Stock Now

2020-03-12 09:32:01 | Here's Why You Should Retain LHC Group LHCG Stock Now

2020-03-11 11:01:03 | Here's Why You Should Retain HMS Holdings HMSY Stock Now

2020-03-06 11:30:04 | Is Accuray ARAY Outperforming Other Medical Stocks This Year?

2020-03-06 09:53:02 | Cooper Companies COO Misses on Q1 Earnings, Lifts View

2020-03-05 07:30:00 | Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

2020-03-04 10:03:03 | Allscripts MDRX Q4 Earnings and Revenues Miss Estimates

2020-03-04 06:31:11 | Veeva Systems VEEV Q4 Earnings and Revenues Beat Estimates

2020-03-04 06:30:11 | Here's Why You Should Hold Avanos Medical AVNS Stock Now

2020-03-02 08:37:01 | DENTSPLY SIRONA XRAY Q4 Earnings Lag Estimates, Sales Rise

2020-03-02 08:37:01 | Glaukos GKOS Q4 Earnings and Revenues Surpass Estimates

2020-03-01 08:45:59 | When Can We Expect A Profit From Accuray Incorporated NASDAQ:ARAY?

2020-02-27 11:30:04 | Why Is Accuray ARAY Down 28.2% Since Last Earnings Report?

2020-02-27 09:56:02 | Avanos AVNS Earnings and Revenues Beat Estimates in Q4

2020-02-27 09:47:02 | OPKO Health OPK Q4 Loss Narrower Than Estimates, Sales Up

2020-02-27 09:39:02 | LHC Group LHCG Q4 Earnings Meet Estimates, Revenues Lag

2020-02-27 09:33:02 | Patterson Companies PDCO Q3 Earnings Top Estimates, Up Y/Y

2020-02-26 09:21:02 | Nevro NVRO Q4 Loss Narrower Than Expected, Revenues Up Y/Y

2020-02-26 09:07:02 | Orthofix OFIX Q4 Earnings Match Estimates, Margins Decline

2020-02-26 09:05:02 | Inogen's INGN Q4 Earnings Miss, Revenues Top Estimates

2020-02-26 09:03:02 | Penumbra PEN Q4 Earnings Beat Estimates, Margins Expand

2020-02-25 09:21:02 | Merit Medical MMSI Q4 Earnings & Revenues Beat Estimates

2020-02-25 07:30:00 | First Accuray CyberKnife® M6™ System Installed in Missouri at Mercy Hospital St. Louis

2020-02-24 09:27:02 | PRA Health PRAH Q4 Earnings and Revenues Beat Estimates

2020-02-24 08:31:01 | HMS Holdings HMSY Q4 Earnings and Revenues Miss Estimates

2020-02-21 09:44:02 | Fresenius Medical FMS Q4 Earnings Beat Estimates, Up Y/Y